BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 30, 2010
View Archived Issues
Actimis discloses novel isotopically enriched prostanoid DP2 receptor antagonists
Read More
Arena Pharmaceuticals claims new receptor S1P1 agonists
Read More
NeuroSearch discovers new voltage-gated K(V)7 potassium channel activators
Read More
Boehringer Ingelheim discloses candidate hepatitis C therapeutic BI-201335
Read More
Acucela claims new agents for treatment of ophthalmic disorders
Read More
Novel histamine H3 receptor antagonists patented by Evotec Neurosciences
Read More
Duke University researchers identify new metabolic biomarker of cardiovascular events
Read More
Data from TROPICS 3/4 trials support tenecteplase for improvement hemodialysis catheter function
Read More
Clinical data disclosed on bevacizumab in metastatic CRC and HCC
Read More
Pfizer details preclinical characteristics of new beta-secretase inhibitors
Read More
Antisoma halts ATTRACT-1 phase III trial of ASA-404
Read More
Potent and selective CB1 receptor antagonist shows promise in mouse model of obesity
Read More
Primera Bioscience Research's project with the Hospital for Sick Children achieves major milestone
Read More
AdventRx to discuss ANX-530 NDA for NSCLC with FDA
Read More
Bioalliance Pharma's antiemetic Setofilm approved in Europe
Read More
Cellceutix reports preclinical data on KM-391 for autism
Read More
Cipher submits NDS to Health Canada for CIP-Tramadol ER for moderately severe pain
Read More
MannKind achieves milestones in collaboration with Multiple Myeloma Research Foundation
Read More
Novavax releases results from phase II trivalent seasonal influenza vaccine trial
Read More
Renovo's phase III Juvista trial fully recruited and on schedule
Read More
LCT receives approval to evaluate higher dose of DiabeCell in unstable diabetes
Read More
EMA approves combination of Xeloda and oxaliplatin for adjuvant treatment of early colon cancer
Read More
Multaq approved and launched in U.K. by sanofi-aventis for management of atrial fibrillation
Read More
GenVec discontinues phase III PACT trial of TNFerade following interim analysis
Read More
Clinuvel advances afamelanotide to phase II following FDA approval of IND
Read More
EMA grants orphan drug designation to Protalix's taliglucerase alfa for Gaucher's disease
Read More